Appointment of Commercial Manager

Summary by AI BETAClose X

One Health Group plc has appointed Joe Hopwood as Commercial Manager to support its growth strategy, leveraging his experience in NHS transformation and commercial oversight. Hopwood's expertise in contractual strategies and elective care commissioning within the NHS is expected to be invaluable as the company continues to expand its provision of NHS-funded surgical procedures. The company previously reported providing care to 18,931 new patients in the year to March 2026, with over 50,000 consultations and 8,000 surgical procedures.

Disclaimer*

One Health Group PLC
06 May 2026
 

A logo with blue and orange letters AI-generated content may be incorrect.

 

One Health Group plc

("One Health", the "Company" or the "Group")

 

Appointment of Commercial Manager

 

One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through 'Patient Choice', announces the appointment of Joe Hopwood as Commercial Manager.

 

Joe joins One Health from NHS South Yorkshire Integrated Care Board where he worked as the transformation and delivery manager. Prior to joining the NHS, Joe was the programme and performance manager at South Yorkshire Police. In his new role at One Health, Joe will be involved in several key areas across the business, including contract negotiations and commercial oversight, and will support the Company in its growth journey and continued execution of its strategy.

 

Joe is skilled in strategic contractual and commercial strategies and stakeholder management with proven national expertise in elective care commissioning legislation, contracts and guidance within the NHS.


Adam Binns, CEO of One Health Group, commented: "This year has been a pivotal period for One Health, and the Board felt now was the right time to further strengthen the management team with this appointment. Joe's NHS experience,
strong commercial awareness, and his analytical capabilities will prove invaluable as we continue to grow and develop. We are delighted to welcome him, and I am confident he will add immense value and insight."


Commenting on his new role, Joe Hopwood said: "I'm thrilled to be joining One Health Group during a period of significant momentum. The team's commitment to improving NHS patient access to high-quality care really stands out, and I'm looking forward to building on this by developing strong partnerships and supporting the Company's continued growth."

 

If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com

 

For more information, please contact:

 

One Health Group plc

Derek Bickerstaff, Chairman

Adam Binns, CEO

 

www.onehealth.co.uk/investors

Via Walbrook PR

Panmure Liberum (Nominated Adviser and Broker)

Emma Earl, Will Goode, Mark Rogers

Rupert Dearden

 

Tel: +44 (0)20 3100 2000

Walbrook PR (Media & Investor Relations)

Alice Woodings / Paul McManus /

Rachel Broad

Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com

Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /

                                                                    +44 (0)7747 515 393

 

A blurry image of people AI-generated content may be incorrect.

 

About One Health Group plc (www.onehealth.co.uk)

One Health engages 88 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2026 provided much needed care to 18,931 new patients, through over 50,000 consultations and over 8,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 140 professionals across 14 independent hospitals and 40 outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.

 

One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from 29 ICBs across England as well as contracts with local NHS trusts to transfer their internal waiting list patients to One Health for quicker treatment.

One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, with urology introduced at the end of FY25.

 

Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.

 

Online investor presentation

Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company's growth strategy and long-term vision:

https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings